| TTM
|
12/31/2023
|
12/31/2022
|
12/31/2021
|
|
|---|---|---|---|---|
| Total Revenue
|
85.3190 | 98.9940 | 206.7670 | 145.9560 |
| Cost of Revenue
|
-29.1770 | -36.7680 | -79.4400 | -42.5440 |
|
Gross Profit
|
56.1420 | 62.2260 | 127.3270 | 103.4120 |
| Selling, General and Administrative Expenses
|
-3,406.9700 | -1,488.0510 | -1,954.5760 | -1,613.0080 |
|
Research and Development Expenses
|
-242.7430 | -560.6540 | -1,452.1280 | -794.7500 |
|
Operating Income/Expenses
|
-3,649.7130 | -2,048.7050 | -3,406.7040 | -2,407.7580 |
|
Total Operating Profit/Loss
|
-3,593.5710 | -1,986.4790 | -3,279.3770 | -2,304.3460 |
| Total Net Finance Income/Expense
|
-365.6790 | -423.2650 | -646.0890 | -611.7940 |
| Net Investment Income
|
134.1430 | 19.1490 | 159.6480 | -44.5050 |
| Irregular Income/Expenses
|
82.5990 | 168.1450 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
0 | 0 | -110.6420 | 0 |
|
Non-Operating Income/Expenses, Total
|
-148.9370 | -235.9710 | -597.0830 | -656.2990 |
|
Pretax Income
|
-3,742.5080 | -2,222.4500 | -3,876.4600 | -2,960.6450 |
|
Provision for Income Tax
|
-2.2500 | -2.2500 | -1.6000 | -0.8000 |
|
Net Income from Continuing Operations
|
-3,744.7580 | -2,224.7000 | -3,878.0600 | -2,961.4450 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,744.7580 | -2,224.7000 | -3,878.0600 | -2,961.4450 |
|
Non-Controlling/Minority Interests
|
1,334.5450 | 54.8860 | 64.0790 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-2,410.2130 | -2,169.8140 | -3,813.9810 | -2,961.4450 |
|
Net Income Available to Common Stockholders
|
-2,410.2130 | -2,169.8140 | -3,813.9810 | -2,961.4450 |
|
Diluted Net Income Available to Common Stockholders
|
-2,410.2130 | -2,169.8140 | -3,813.9810 | -2,961.4450 |
| Basic EPS
|
-0.00 | -0.00 | -0.00 | -0.00 |
| Diluted EPS
|
-0.00 | -0.00 | -0.00 | -0.00 |
|
Basic Weighted Average Shares Outstanding
|
4,274,780.3330 | 3,168,900.8010 | 2,528,062.9580 | 2,263,126.9700 |
|
Diluted Weighted Average Shares Outstanding
|
4,274,780.3330 | 3,168,900.8010 | 2,528,062.9580 | 2,263,126.9700 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-3,376.8290 | -1,799.1850 | -3,230.3710 | -2,348.8510 |
|
EBITDA
|
-3,065.0510 | -1,487.4070 | -2,985.7400 | -2,330.7840 |
|
Normalized EBITDA
|
-299.8490 | -1,279.1560 | -1,633.5950 | -1,486.2500 |
|
Normalized Income
|
-1,560.2484 | -2,060.1817 | -2,809.8655 | -2,344.9352 |
|
Total Unusual Items
|
2,765.2020 | 208.2510 | 1,352.1450 | 844.5340 |
12/31/2021 - 6/24/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade